Trials / Conditions / Non-Small Cell Adenocarcinoma
Non-Small Cell Adenocarcinoma
5 registered clinical trials studyying Non-Small Cell Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With NCT06810544 | Tango Therapeutics, Inc. | Phase 1 / Phase 2 |
| Terminated | Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors NCT04985604 | Day One Biopharmaceuticals, Inc. | Phase 2 |
| Completed | First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b NCT06517485 | Mersana Therapeutics | Phase 1 |
| Unknown | Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer NCT06207292 | Radiotherapy Oncology Centre "Santa Maria" Hospital | N/A |
| Unknown | Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma NCT03071705 | Instituto Nacional de Cancerologia de Mexico | N/A |